SEARCH · PubMed Health

Results for “Particle Accelerators”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,009 records · Page 56Linked to original sources

PubMed2005

Comparison of radiosurgery planning modalities for acoustic neuroma with regard to conformity and mean target dose.

PURPOSE: To evaluate dose conformity and mean target dose in light of previous comparative studies and state-of-the-art radiosurgery delivery modalities. MATERIALS AND METHODS: Seven patients with acoustic neuromas deemed clinically suitable for linear accelerator or Gamma Knife radiosurgery were planned such that the minimum doses for any plan were equal. Gamma Knife plans were prepared in three ways: by altering the prescription of previously published data, by hand and with the assistance of an automatic planning algorithm (wizard). The linear accelerator plans were prepared utilizing a micro-multileaf collimator in both static and dynamic modes. The dose volume histogram analyses lead to a measure of conformity and the mean and minimum target dose for each plan. Statistical significance was calculated as each planning modality was compared with every other. RESULTS: All Gamma Knife plans demonstrated a statistically significantly better conformity when compared with fixed field linear accelerator techniques. When compared to linear accelerator techniques the wizard-assisted Gamma Knife plans demonstrated significantly better conformity. The mean target dose for all the Gamma Knife plans was significantly higher than that of the linear accelerator plans (19.2 Gy vs. 13.4 Gy). CONCLUSIONS: Conformity of the prescription isodose to the target shape is of major importance in radiosurgery. The modalities compared represent commercially available and widely accepted systems. Gamma Knife plans derived using the 'wizard' option and finalized by hand yield the best conformity.

Algorithms↗

PubMed2001

Quantitative analysis of errors in fractionated stereotactic radiotherapy.

Fractionated stereotactic radiotherapy (FSRT) offers a technique to minimize the absorbed dose to normal tissues; therefore, quality assurance is essential for these procedures. In this study, quality assurance for FSRT of 58 cases, between August 1995 and August 1997 are described, and the errors for each step and overall accuracy were estimated. Some of the important items for FSRT procedures are: accuracy in CT localization, transferred image distortion, laser alignment, isocentric accuracy of linear accelerator, head frame movement, portal verification, and various human errors. A geometric phantom, that has known coordinates was used to estimate the accuracy of CT localization. A treatment planning computer was used for checking the transferred image distortion. The mechanical isocenter standard (MIS), rectilinear phantom pointer: (RLPP), and laser target localizer frame (LTLF) were used for laser alignment and target coordinates setting. Head-frame stability check was performed by a depth confirmation helmet (DCH). A film test was done to check isocentric accuracy and portal verification. All measured data for the 58 patients were recorded and analyzed for each item. 4-MV x-rays from a linear accelerator, were used for FSRT, along with homemade circular cones with diameters from 20 to 70 mm (interval: 5 mm). The accuracy in CT localization was 1.2+/-0.5 mm. The isocentric accuracy of the linear accelerator, including laser alignment, was 0.5+/-0.2 mm. The reproducibility of the head frame was 1.1+/-0.6 mm. The overall accuracy was 1.7+/-0.7 mm, excluding human errors.

Brain Neoplasms↗

PubMed2002

Estimation of shielding factors for linear accelerators.

There have been a number of persons who have estimated that the use of multi-leaf collimation and IMRT techniques increase the workload in treatment rooms to the extent that assumptions used in shielding calculations should reflect these increased workloads. This paper examines the workloads in a large department with treatment machines of varying energies and techniques. While the sample size examined is limited, the data presented demonstrate that the standard assumptions may still be sufficiently conservative that no substantive changes may be needed.

Humans↗

PubMed1981

Electron beam dose calculations.

Electron beam dose distributions in the presence of inhomogeneous tissue are calculated by an algorithm that sums the dose distribution of individual pencil beams. The off-axis dependence of the pencil beam dose distribution is described by the Fermi-Eyges theory of thick-target multiple Coulomb scattering. Measured square-field depth-dose data serve as input for the calculations. Air gap corrections are incorporated and use data from'in-air' measurements in the penumbra of the beam. The effective depth, used to evaluate depth-dose, and the sigma of the off-axis Gaussian spread against depth are calculated by recursion relations from a CT data matrix for the material underlying individual pencil beams. The correlation of CT number with relative linear stopping power and relative linear scattering power for various tissues is shown. The results of calculations are verified by comparison with measurements in a 17 MeV electron beam from the Therac 20 linear accelerator. Calculated isodose lines agree nominally to within 2 mm of measurements in a water phantom. Similar agreement is observed in cork slabs simulating lung. Calculations beneath a bone substitute illustrate a weakness in the calculation. Finally a case of carcinoma in the maxillary antrum is studied. The theory suggests an alternative method for the calculation of depth-dose of rectangular fields.

Electrons↗

PubMed1999

Extension of CadPlan algorithm to model the dose distribution under a motorized wedge.

The CadPlan treatment planning system models the dose distribution in the non-wedge direction under a wedged field by converting the wedge thickness to an equivalent water thickness. The algorithm estimates the off-axis ratio (OAR) in the non-wedged direction using the open field OAR at a depth deeper by this equivalent water thickness. This model has been shown to work well for a Siemens Mevatron KD-2 Linac. However, the motorized wedge of the Elekta (formerly Philips) accelerators is tapered off-axis to give a flat dose profile in the non-wedged direction. The CadPlan model assumes that the wedge has a uniform thickness in the non-wedged direction and so cannot model the off-axis dose for the motorized wedge. For a 4 MV beam of a SL75/5 accelerator this leads to a 7% overestimate and a 9% underestimate of the OAR under the thin and thick edge of the wedge respectively. For 6 and 18 MV beams of a SL20 accelerator and a 6 MV beam of a SL75/5 accelerator, the model underestimates the OAR in the order of 10% under the thick end of the wedge. We have shown that by appropriate modification of the effective water thickness values at off-axis distances, the algorithm models the OAR in the non-wedged direction to within 2.5% of the measured values for the 4, 6 and 18 MV beams, for the Elekta motorized wedge.

Algorithms↗

PubMed2004

A practical method to calculate head scatter factors in wedged rectangular and irregular MLC shaped beams for external and internal wedges.

Factor based methods for absorbed dose or monitor unit calculations are often based on separate data sets for open and wedged beams. The determination of basic beam parameters can be rather time consuming, unless equivalent square methods are applied. When considering irregular wedged beams shaped with a multileaf collimator, parametrization methods for dosimetric quantities, e.g. output ratios or wedge factors as a function of field size and shape, become even more important. A practical method is presented to derive wedged output ratios in air (S(c,w)) for any rectangular field and for any irregular MLC shaped beam. This method was based on open field output ratios in air (S(c)) for a field with the same collimator setting, and a relation f(w) between S(c,w) and S(c). The relation f(w) can be determined from measured output ratios in air for a few open and wedged fields including the maximum wedged field size. The function f(w) and its parametrization were dependent on wedge angle and treatment head design, i.e. they were different for internal and external wedges. The proposed method was tested for rectangular wedged fields on three accelerators with internal wedges (GE, Elekta, BBC) and two accelerators with external wedges (Varian). For symmetric regular beams the average deviation between calculated and measured S(c,w) / S(c) ratios was 0.3% for external wedges and about 0.6% for internal wedges. Maximum deviations of 1.8% were obtained for elongated rectangular fields on the GE and ELEKTA linacs with an internal wedge. The same accuracy was achieved for irregular MLC shaped wedged beams on the accelerators with MLC and internal wedges (GE and Elekta), with an average deviation < 1% for the fields tested. The proposed method to determine output ratios in air for wedged beams from output ratios of open beams, combined with equivalent square approaches, can be easily integrated in empirical or semi-empirical methods for monitor unit calculations.

Algorithms↗

PubMedDate not supplied

Spectral characterization of 4 MV Bremsstrahlung by attenuation analysis.

The "quality of radiation" for a high energy x-ray beam can be specified by its attenuation curve in a selected material. The inverse Laplace transform of the attenuation curve can be used as an approximate indication of the energy spectrum of the beam. Existing mathematical procedures for this purpose have been evaluated and were found to poorly represent measured transmission data for 4 MV x-rays from a linear accelerator. The transmission data between 1 and 0.002 could be fitted within the experimental uncertainty by expressing the logarithmic transmission as a second order polynomial of attenuator thickness. The inverse Laplace transform them becomes a Gaussian function of the attenuation coefficient. This new version of "attenuation analysis" provides a practical method for specification of the quality of the radiation in this energy range.

Models, Theoretical↗

PubMedDate not supplied

Cost effectiveness of linear accelerators.

Cost analysis of radiation therapy and cost benefit analysis of Co60 versus linear accelerator therapy are useful exercises for radiation therapy departments. Such analysis will show that the costs of radiation therapy are significant. However, the cost benefit is most likely to be seen where survival is increased and morbidity is decreased. In centers where there is a high population of patients treated for palliation, the cost benefit is unlikely to be realized.

Cobalt Radioisotopes↗

PubMed1992

[Proton irradiation synchronized with respiratory cycle].

A sensitive strain gauge was used to detect the movement of the chest wall in order to synchronize an irradiation control system with the respiratory cycle. The output timing signal from the system is transferred to the proton accelerator for synchronized irradiation. The timing signal is set during the expiratory phase at a duration of 1.5 to 2 seconds. The efficacy of this method was evaluated by dose volume histogram based on the treatment planning program with CT images. The volume spared by this novel method was calculated in several cases, and results suggest that the method was highly effective.

Humans↗

PubMed1992

Determination of virtual SSDs for electron beams from a dual energy linear accelerator.

Electron beams from an accelerator appear to originate from a point away from the vacuum window designated as virtual source. Virtual source to isocenter distances are determined experimentally by measurements in a polystyrene phantom with inverse square law method. Corrections required for percentage depth dose are also determined. Results of our study are compared with that of other investigators.

Electrons↗

PubMed1990

Role of stereotactic radiosurgery with a linear accelerator in treatment of intracranial arteriovenous malformations and tumors in children.

Between 1986 and 1988, 16 children were treated for 10 arteriovenous malformations and 6 recurrent intracranial tumors with stereotactic radiation therapy using a modified Clinac 6/100 linear accelerator. The median age of our patients was 10.5 years. For the group with arteriovenous malformation, follow-up ranged from 6 months to 37 months (median was 20 months). No patient bled during the follow-up period. Five of eight patients with follow-up longer than 12 months have achieved complete obliteration of their arteriovenous malformation by angiogram. The four remaining patients who have not achieved a complete obliteration are awaiting their 2-year posttreatment angiogram. The other patient has been treated within the year and have not yet been studied. Five of the six recurrent tumor patients are alive with a median follow-up of 8 months. The remaining patient was controlled locally, but he died of recurrent disease outside the area treated with radiosurgery. The radiographic responses of these patients have included three complete responses, two substantial reductions in tumor volume (greater than 50%) and one stabilization. Despite previous radiotherapy, there have been no significant complications in these patients. We conclude that stereotactic radiation therapy using a standard linear accelerator is an effective and safe technique in the treatment of selected intracranial arteriovenous malformations and tumors in children. In addition, stereotactic radiosurgery may have unique applications in the treatment of localized primary and recurrent pediatric brain tumors.

Adolescent↗

PubMed1989

[The Mevatrom KD 80/67 linear accelerator].

Technical equipment of radiotherapeutic wards is presently supplemented with irradiators on the principle of a linear accelerator. The paper briefly describes the principle of linear accelerator with standing wave and its basic technical parameters. Data on electric, mechanic and densitometric properties of this apparatus and accessories are presented. Therapeutic beams of bremsstrahlung and electron radiation were characterized in the whole range of energy, i.e. 0.961 and 3.204 pJ (6 and 20 MV) for bremsstrahlung and 0.961 to 3.364 pJ (6 to 21 MeV) for electron radiation. In the last part the performed hygienic measurements are also described.

Particle Accelerators↗

PubMedDate not supplied

Stereotactic radiosurgery of intracranial tumors in childhood.

The Authors have developed an original stereotactic technique by which the radiation dose erogated by a 4 MV linear accelerator is focused into the target volume with a steep dose gradient at its borders. The technique has been employed in a series of 30 patients affected by deep seated brain tumors and AVMs. The paper deals with the preliminary results obtained in a series of 10 patients in pediatric age.

Adolescent↗

PubMed1978

A catalytic generator for the production of H2 14O and H2 15O.

A technique is described for the continuous production of water labelled with 14O or 15O. Total activities are achieved which are virtually independent of the distance separating the accelerator from the user site, limited only by beam current and energy. The specific activity is determined by the user's needs, since the entire 100-mCi inventory can be collected in liquid volumes on the order of microliters. The studies triggered by this resource range from basic investigations in physics and biochemistry to practical nuclear medical procedures.

Isotope Labeling↗

PubMed1983

Energy of proton accelerator necessary for treatment of choroidal melanomas.

We have reviewed 94 patients with choroidal melanoma treated by proton beam therapy at the Harvard Cyclotron Laboratory. A beam penetration of f27 mm would be required to treat 90% of the lesions. We conclude that a machine energy of at least 55 and, preferably, 60 MeV would be necessary for a clinically viable therapy unit for the treatment of choroidal melanomas. An extracted beam current of 10(-9) A would be more than sufficient.

Choroid Neoplasms↗

PubMed2001

Production of terbium-152 by heavy ion reactions and proton induced spallation.

Terbium-152 (Tb-152) is of potential value as a radiotracer for radiolanthanides in positron emission tomography. We report the production of Tb-152 by heavy ion reactions at the ANU Tandem accelerator, and by the spallation method at the CERN proton accelerator using the on-line ISOLDE separator, obtaining microcurie and millicurie yields, respectively. After purification, a phantom image in PET is obtained which shows the feasibility of using Tb-152 for monitoring the kinetics of Tb-149 and other radiolanthanides. However, the current availability of this radioisotope will be restricted to major nuclear physics research centres.

Kinetics↗

PubMed1999

Refinement of the basic treatment equivalent model to reflect radiotherapy treatment throughput using Australasian data.

A model of radiotherapy linear accelerator throughput has been developed and shown to be a more sensitive measure of throughput than current measures of throughput. The present study aims to develop a more sensitive basic treatment equivalent (BTE) model that still measures linear accelerator throughput and considers some of the shortcomings of the previous model. All radiation oncology departments in Australia and New Zealand were invited to participate. Departments were asked to time with a stopwatch all episodes of radiotherapy treatment over a 4-week period. Data collected for each treatment fraction included treatment intent, tumour site, patient age, Eastern Cooperative Oncology Group (ECOG) performance status, number of fields used, number of wedges used, number of junctions, number of shielding blocks used, whether the treatment was the first fraction, the use of general anaesthesia and whether port films or electronic portal imaging was used. Twenty-six departments of radiation oncology (70%) participated in this trial. A total of 7929 fractions of treatment, administered to 2424 patients, were timed. The factors found to most significantly impact on treatment duration on multivariate analysis were the type of fraction (first fraction was longer than subsequent fractions), type of beam (electrons were quicker than photons, which were quicker than mixed), number of fields, number of shields, number of junctions, number of port films and performance status (ECOG < 2 vs > 2). The age of the patient, number of compensators and the sex of the patient were not significant. The relationships between factors were assessed, and models of measuring linear accelerator throughput which consider complexity corrections were derived. It is possible to show that linear accelerator throughput is poorly measured by just considering numbers of patients or fields treated per unit time; and that other factors that impact on treatment duration must be considered. A more sensitive model of patient throughput is suggested; but even when a large number of factors are considered, some insensitivity still remains in the model.

Australia↗

PubMed1993

Current developments in proton therapy: a review.

The use of high-energy protons in radiotherapy was first proposed in 1946. In the last decade there has been a significant growth in the number of centres using protons in the treatment of malignant and non-malignant disease. To date (January 1993) a total of more than 11,500 patients have been treated world-wide. Encouraging clinical results have been reported in the literature. The purpose of this article is to outline the advantages of proton beams and to review current developments in physics and engineering applied to the field of proton therapy with particular emphasis on proton accelerator technology and the development of proton therapy facilities. The production of clinically useful beams is discussed and the relative merits of different treatment systems compared. Reference is also made to the factors affecting the absorbed dose in a patient and to proton radiobiology together with the results of studies of comparisons of treatment planning with protons with that using conventional photon therapy. The dosimetry of proton beams is also reviewed.

Humans↗